Medicamen Biotech Limited

MEDICAMEQ

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 202644

    Quarter₹ croreYoY
    Jun 202441+2.4%
    Sept 202443+0.4%
    Dec 202441-6.9%
    Mar 202526-42.2%
    Jun 202538-7.3%
    Sept 202542-1.4%
    Dec 202543+5.7%
    Mar 202655+110.3%
    Jun 202644+14.1%
  • ₹ crore

    Jun 20260.86

    Quarter₹ crore
    Jun 20240.58
    Sept 20240.29
    Dec 20240.14
    Mar 20255
    Jun 20250.47
    Sept 20250.37
    Dec 20250.53
    Mar 20262
    Jun 20260.86
  • ₹ crore

    Jun 202645

    Quarter₹ crore
    Jun 202442
    Sept 202443
    Dec 202441
    Mar 202531
    Jun 202539
    Sept 202543
    Dec 202544
    Mar 202656
    Jun 202645
  • Cost structure
  • ₹ crore

    Jun 20266

    Quarter₹ crore
    Jun 20245
    Sept 20245
    Dec 20245
    Mar 20256
    Jun 20255
    Sept 20256
    Dec 20256
    Mar 20266
    Jun 20266
  • ₹ crore

    Jun 202641

    Quarter₹ crore
    Jun 202439
    Sept 202440
    Dec 202438
    Mar 202528
    Jun 202537
    Sept 202540
    Dec 202541
    Mar 202653
    Jun 202641
  • Exceptional items and tax
  • ₹ crore

    Jun 20263

    Quarter₹ crore
    Jun 20243
    Sept 20243
    Dec 20243
    Mar 20253
    Jun 20252
    Sept 20253
    Dec 20253
    Mar 20264
    Jun 20263
  • ₹ crore

    Jun 20260.73

    Quarter₹ crore
    Jun 20240.76
    Sept 20240.99
    Dec 20240.96
    Mar 20250.63
    Jun 20250.53
    Sept 20250.56
    Dec 20250.49
    Mar 20260.56
    Jun 20260.73
  • Profit
  • ₹ crore

    Jun 20263

    Quarter₹ croreYoY
    Jun 20242-48.9%
    Sept 20242-24.7%
    Dec 20243-8.8%
    Mar 20252-22.3%
    Jun 20252-27.5%
    Sept 20252-2.8%
    Dec 20253+2.8%
    Mar 20263+23.3%
    Jun 20263+54.4%
  • Per share
  • ₹ per share

    Jun 20261.86

    Quarter₹ per share
    Jun 20241.78
    Sept 20240.00
    Dec 20241.98
    Mar 20251.90
    Jun 20251.21
    Sept 20251.63
    Dec 20251.91
    Mar 20262.19
    Jun 20261.86
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
414341263842435544
Revenue YoY+2.4%+0.4%-6.9%-42.2%-7.3%-1.4%+5.7%+110.3%+14.1%
0.580.290.1450.470.370.5320.86
424341313943445645
Cost structure
555656666
394038283740415341
Exceptional items and tax
333323343
0.760.990.960.630.530.560.490.560.73
Profit
223222333
Net profit YoY-48.9%-24.7%-8.8%-22.3%-27.5%-2.8%+2.8%+23.3%+54.4%
Per share
1.780.001.981.901.211.631.912.191.86

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.